Citations

Institution: Mayo Clinic Clear

Showing 10 of 108152 citations.

Invited Commentary: Radiology at the Forefront in the Fight against Metabolic Dysfunction–associated Steatotic Liver Disease
Venkatesh, Sudhakar K. , Venkatesh, Sudhakar K

RadioGraphics | October 17, 2024 | Volume: 44 | Issue: 11 | Pages: No page available

10.1148/rg.240209 | PMID 39418185 Get It

Carfilzomib Prescribing Patterns and Outcomes for Relapsed or Refractory Multiple Myeloma: A Real-World Analysis
Dong, Sharlene , Banerjee, Rahul , Khan, Adeel , Wang, Xiaoliang , Afghahi, Anosheh , Afrough, Aimaz , Janakiram, Murali , Cowan, Andrew J. , Banerjee, Rahul , Wang, Xiaoliang , Janakiram, Murali , Wang, Mengru , Wang, Bo , Sperling, Adam S. , Anderson, Larry D. , Rajkumar, S. Vincent , Kaur, Gurbakhash

No container title available | October 17, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-4839164/v1 Get It

Abstract Despite the widespread use of carfilzomib (K) in relapsed/refractory multiple myeloma (RRMM), there is no consensus on optimal K dose in milligrams per square meter (mg/m2) or dosing schedule. We assessed three modern K prescribing patterns in RRMM using a large United States electronic health record-derived database. Our final cohort (n = 486) included 136 patients (28.0%) who received K 56 mg/m2 once weekly (K56-1x), 86 (17.7%) who received 56 mg/m2 twice weekly (K56-2x), and 264 (54.3%) who received 70 mg/m2 once weekly (K70-1x). Between 2016 and 2023, once-weekly dosing became more common: K70-1x proportions changed from 21.1% in 2016 to 50.6% in 2023, K56-1x from 15.8% to 37.0%, and K56-2x from 63.2% to 12.3%. Median real-world progression-free survival was 13.0 months [95% confidence interval (CI) 11.2-20.7] for K56-1x, 13.2 months (95% CI 9.0-28.1 months) for K56-2x, and 10.9 months (95% CI 9.9-15.3 months) for K70-1x; these differences were not statistically significant (log-rank p = 0.46). The prevalence of heart failure was comparable (<5% in all cohorts). In summary, our findings do not support improved outcomes with twice-weekly carfilzomib in RRMM. K56-1x may provide the best balance of efficacy, safety, and avoidance of time toxicity from frequent infusions.
Identification of patients on chronic prescription opioids at risk for opioid use disorder using pharmacy claims data
Jantzen, Aleesha, Hall, Scott T. , Cunningham, Julie L. , Odell, Laura, Hall, Scott Thomas , Lai, Benjamin , Lai, Benjamin

Journal of Healthcare Risk Management | October 17, 2024 | Volume: 44 | Issue: 2 | Pages: 14-19

10.1002/jhrm.21585 | PMID 39418134 Get It

AbstractUsing pharmacy claims data from a single commercial health plan to identify opportunities for opioid use disorder (OUD) focused screening and interventions communicated via targeted prescriber messaging. Participants included members ≥18 years using more than 90 morphine milligram equivalents (MMED) daily based on all opioid claims, had >1 paid claim for an opioid product, and had ≥90 days of total opioid therapy. Members were excluded with ≥1 claims for an oral chemotherapy agent (except methotrexate). Intervention was completed with a secure communication to the primary outpatient opioid prescriber that included resources for diagnosis, treatment, and best practices for opioid prescribing. The main outcome measure was any documented change to opioid use following the intervention. Seven hundred forty‐five members were identified; a subset (n = 20) was further assessed, and all had identified OUD risk factors; providers were subsequently sent a communication. Sixteen providers acknowledged receipt and 11 patients (55%) had at least one documented intervention following communication receipt. Provision of targeted, evidence‐based recommendations to providers for patients identified to be at risk of OUD from pharmacy claims data can result in increased recognition and intervention. Future efforts to explore feasibility of provider education detailing efforts and continued evaluation of efficacy are needed.
Low magnesium levels and prognosis in newly diagnosed diffuse large B-cell lymphoma
Gile, Jennifer , Maurer, Matthew J. , Ruan, Gordon , Abeykoon, Jithma P. , Heimgartner, Joy , Baumann, N, McMahon, Molly, Gile, Jennifer Jane , Maurer, Matthew , Ruan, Gordon J , Heimgartner, Joy R, Baumann, Nikola A, Lin, Yi , Witzig, Thomas E.

The Oncologist | October 17, 2024 | Volume: 29 | Issue: 12 | Pages: e1779-e1782

10.1093/oncolo/oyae255 | PMID 39418117 Get It

Abstract Magnesium (Mg) is an essential element involved in cellular metabolism. We demonstrated that in patients with diffuse large B-cell lymphoma (DLBCL) undergoing autologous stem cell transplant (SCT), those with a serum Mg &lt; 2.0 mg/dL at the time of transplant had worse outcomes. In this study, we aimed to learn the prognostic value of low serum Mg in patients with untreated DLBCL. We analyzed serum from 408 patients and tested 2 Mg cutpoints—low (&lt;1.7 mg/dL) and low normal (&lt;2.0 mg/dL), a range we found associated with lower survival in the SCT group. We found 3% of patients with low levels and 23% with low normal levels. Low normal serum Mg levels were associated with a higher stage at diagnosis, more extranodal involvement, higher international prognostic index score, lower overall survival (OS), and event-free survival. These data warrant testing Mg replacement to a target of &gt;2.0 mg/dL to learn if survival can be improved.
The Use of Grayscale Muscle Ultrasound to Indicate Muscle Recovery after Peripheral Nerve Reconstruction
Saffari, Sara , Boon, Andrea J. , Saffari, Seyed Ehsan , Saffari, Seyed Ehsan , Shin, Alexander Y.

Plastic & Reconstructive Surgery | October 17, 2024 | Volume: 155 | Issue: 4 | Pages: 709-719

10.1097/prs.0000000000011811 | PMID 39418075 Get It

Background: This study aimed to validate the use of grayscale muscle ultrasound by measuring echo intensity to longitudinally evaluate functional muscle reinnervation in a rabbit peroneal nerve defect model. Methods: Eighteen New Zealand white rabbits underwent a 30-mm peroneal nerve reconstruction with autografts or decellularized allografts. Ultrasound measurements of tibialis anterior muscles were performed before surgery and at 4, 8, 12, 16, 20, and 24 weeks postoperatively and included cross-sectional muscle area, mean gray value (MGV), and mean gray value normalized for area (MGVA). At 24 weeks, functional motor recovery was evaluated with isometric tetanic force (ITF) and compound muscle action potential (CMAP). MGVA data were compared with ITF and CMAP measurements by calculating the Spearman correlation coefficient. Results: Muscle area (left/right [L/R] ratio) of autografts was superior to allografts at 4, 12, 16, 20, and 24 weeks (P < 0.03 for all comparisons). MGVs of the operated side were significantly higher for autografts at 4, 8, and 12 weeks and at 12, 16, 20, and 24 weeks for allografts (P < 0.01 for all comparisons), compared with their unoperated sides. Similar patterns were seen in both groups for MGVA (operated versus control side). MGVA (L/R) demonstrated a strong correlation with ITF (L/R) for autografts (ρ = −0.7) and allografts (ρ = −0.87), but inconsistent with CMAPs (L/R). Conclusions: Quantitative muscle ultrasound demonstrated a reliable, noninvasive tool for evaluating motor recovery in a rabbit peroneal nerve reconstruction model. Clinical translation could provide valuable insights into muscle health and structural changes following nerve reconstruction.
The IGF System and Aging
Conover, Cheryl A. , Oxvig, Claus

Endocrine Reviews | October 17, 2024 | Volume: 46 | Issue: 2 | Pages: 214-223

10.1210/endrev/bnae029 | PMID 39418083 Get It

Abstract There is strong evidence that IGF signaling is involved in fundamental aspects of the aging process. However, the extracellular part of the IGF system is complex with various receptors, ligand effectors, high-affinity IGF-binding proteins, proteinases, and endogenous inhibitors that all, along with their biological context, must be considered. The IGF system components are evolutionarily conserved, underscoring the importance of understanding this system in physiology and pathophysiology. This review will briefly describe the different components of the IGF system and then discuss past and current literature regarding IGF and aging, with a focus on cellular senescence, model organisms of aging, centenarian genetics, and 3 age-related diseases—pulmonary fibrosis, Alzheimer disease, and macular degeneration—in appropriate murine models and in humans. Commonalities in mechanism suggest conditions where IGF system components may be disease drivers and potential targets in promoting healthy aging in humans.
Best practices and pragmatic approaches for patient-reported outcomes and quality of life measures in cancer clinical trials
Bandos, Hanna , Torres‐Saavedra, Pedro A. , Lee, Minji K. , Duan, Fenghai , Cecchini, Reena S. , Dueck, Amylou C. , Dueck, A. C. , Gunn, Heather J., Culakova, Eva , Gunn, Heather , Unger, Joseph M. , Steingrimsson, Jon Arni

JNCI Monographs | October 17, 2024 | Volume: 2025 | Issue: 68 | Pages: 14-21

10.1093/jncimonographs/lgae047 | PMID 39989038 Get It

Abstract Patient-reported outcomes (PROs) are often collected in cancer clinical trials. Data obtained from trials with PROs are essential in evaluating participant experiences relating to symptoms, financial toxicity, or health-related quality of life. Although most features of clinical trial design, implementation, and analyses apply to trials with PROs, several considerations are unique. In this paper, we focus on specific issues such as selection of the tool, timing and frequency of assessments, and data collection methods. We discuss how the estimand framework can be used in connection with PROs, properties of common estimation methods, and handling of missing outcomes. With a plethora of literature available, we aim to summarize best practices and pragmatic approaches to the design and analysis of the studies incorporating PROs.
ECPELLA Mixing Cloud on Computed Tomography Angiogram
Tsikvadze, Mariam , Haney, John C. , Lyle, Melissa , Shapiro, Anna Bovill

Anesthesiology | October 17, 2024 | Volume: 142 | Issue: 1 | Pages: 176-177

10.1097/aln.0000000000005169 | PMID 39417837 Get It

The current state of digital pathology, molecular diagnostics and biobanking in renal cancer: Kidney Cancer Association Consensus Statement
Leibovich, Bradley C. , George, Daniel J. , Pickering, Lisa , Blackmur, James Peter , Jones, James O. , Laird, Alexander , Warren, Anne Y. , George, Daniel J. , Rosa, Salvatore La , Stewart, Grant D.

Medicom Conference Report Proceedings of the 2024 IKCS: Europe Symposium | October 17, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.55788/bba1f0bd Get It

Feasibility of thin-slice, low noise images created using multi-kernel synthesis to replace multiple image series in head CT
Diehn, Felix E. , Nagelschneider, Alex A. , Passe, Theodore J. , Nelson, Brandon , Cardona, Daniel Gomez , Huber, Nathan R. , Missert, Andrew D, Yu, Lifeng , Johnson, Matthew P. , Holmes, David R. , Lee, Yong S. , Thorne, Jamison E. , Diehn, Felix E , DeLone, David R. , Nelson, Brandon J, Gomez Cardona, Daniel G , Thorne, Jamison E , Fletcher, Joel G , Inoue, Akitoshi , Missert, Andrew D, Yu, Lifeng , McCollough, Cynthia H. , Fletcher, Joel G.

Acta Radiologica | October 17, 2024 | Volume: 65 | Issue: 11 | Pages: 1411-1421

10.1177/02841851241280365 | PMID 39415759 Get It

Background SynthesiZed Improved Resolution and Concurrent nOise reductioN (ZIRCON) is a multi-kernel synthesis method that creates a single series of thin-slice computed tomography (CT) images displaying low noise and high spatial resolution, increasing reader efficiency and minimizing partial volume averaging. Purpose To compare the diagnostic performance of a single set of ZIRCON images to two routine clinical image series using conventional CT head and bone reconstruction kernels for diagnosing intracranial findings and fractures in patients with trauma or suspected acute neurologic deficit. Material and Methods In total, 50 patients underwent clinically indicated head CT in the ER (15 normal, 35 abnormal cases). A non-reader neuroradiologist established the reference standard. Three neuroradiologists reviewed two routine clinical series (head and bone kernels) and a single ZIRCON series, detecting intracranial findings or fractures and rating confidence (0–100). Sensitivity, specificity, and jackknife free-response receiver operating characteristic (JAFROC) figure of merit (FOM) were compared (limit of non-inferiority: −0.10). Results ZIRCON and conventional images demonstrated comparable performance for fractures (sensitivity: 51.5% vs. 54.5%; specificity: 40.2% vs. 34.2%) and intracranial findings (sensitivity: 88.2% vs. 91.4%; specificity: 77.2% vs. 73.7%).The estimated difference of JAFROC FOM demonstrated ZIRCON non-inferiority for acute pathologies overall (0.003 [95% CI=−0.051–0.057]) and fractures (0.048 [95% CI=−0.050–0.145]) but not for intracranial findings alone (−0.024 [95% CI=−0.100–0.052]). Conclusion Thin-slice, low noise, and high spatial resolution images can be created to display intracranial findings and fractures replacing multiple images series in head CT with similar performance. Future studies in more patients and further algorithmic development are warranted.